Invests in
Stages:
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Rob
Investments
Work Experience
2007
Partner
2007
Life science and health technology venture capital, growth equity and mission-driven company building
Director
2024
Web-based patient experience and automation suite for medical practices
2024
Founding Investor, Director
2024
Cells as reagents
2023
Director
2023
Providing rural market access to exceptional mental healthcare
2023
Director
2023
Home-based, community and remote health care for those in need
Director
2020
Specialty and generic pharmaceuticals, re-shoring
2019
Director
2019
Peptide drug discovery
Director
2019
Safeguarding patients through monitoring compliance IT/hardware
2017 - 2023
Director
2017 - 2023
Unlocking power of NGS for human identification. Acquired by Qiagen (NYSE:QGEN)
2019 - 2022
Secretary and Board Observer
2019 - 2022
Rapid antibiotic susceptibility testing. Acquired by bioMérieux S.A. (ENXTPA:BIM)